NEUPATH HEALTH ANNOUNCES EXECUTIVE LEADERSHIP CHANGES AS PART OF PLANNED TRANSITION, PRE-ANNOUNCES STRONG 2025 RESULTS

Executive Summary

• Stephen Lemieux will become CEO of NeuPath Health Inc. on April 1, 2026, succeeding Joseph Walewicz, who will remain on the Board and serve as a consultant.
• Sandee Dela Cruz is promoted to Chief Information Officer effective January 1, 2026.
• The company provides preliminary 2025 financial guidance: revenue $86‑$88 million (up from $72.8 M in 2024) and Adjusted EBITDA $5.6‑$6.0 million (up from $3.8 M in 2024).

Key Details

• CEO Transition: Stephen Lemieux, currently President, assumes the CEO role on April 1, 2026; Joseph Walewicz stays on the Board and in a consulting capacity.
• CIO Promotion: Sandee Dela Cruz promoted to Chief Information Officer, effective January 1, 2026.
• Preliminary 2025 Revenue Guidance: Expected range $86 million – $88 million (vs. $72.8 M for FY‑2024).
• Preliminary 2025 Adjusted EBITDA Guidance: Expected range $5.6 million – $6.0 million (vs. $3.8 M for FY‑2024).
• Reporting Date: Audited FY‑2025 results to be released on March 26, 2026.
• Management Backgrounds:
• Stephen Lemieux brings >20 years in finance/operations, prior CFO and interim CEO roles, and experience with acquisitions (e.g., HealthPointe 2021).
• Sandee Dela Cruz has >20 years in IT leadership, previously VP of IT at NeuPath, recognized as a top mid‑market CIO.
• Board Comment: Jolyon Burton highlighted Joe’s contributions and expressed confidence in the new executive team’s ability to execute growth strategy.

Notable Quotes

“I am honoured to become NeuPath’s next CEO… I look forward to working with our talented and passionate team, as we continue to grow our business,” – Stephen Lemieux, incoming CEO.

“The Board and I would like to thank Joe for his leadership… With Stephen as CEO, Jeff Zygouras as CFO, and Sandee as CIO, we are confident in the continued success and execution of NeuPath’s significant growth strategy.” – Jolyon Burton, Director & shareholder.